SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-007129
Filing Date
2017-08-09
Accepted
2017-08-09 16:06:31
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q2_10Q2017.htm 10-Q 876488
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 18182
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 18040
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 6663
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 6852
  Complete submission text file 0001654954-17-007129.txt   3069180

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20170630.xml EX-101.INS 375776
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20170630.xsd EX-101.SCH 41618
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20170630_cal.xml EX-101.CAL 44088
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20170630_def.xml EX-101.DEF 129841
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20170630_lab.xml EX-101.LAB 261926
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20170630_pre.xml EX-101.PRE 198327
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 171017891
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences